Navigation Links
IBD emerges as a global disease

The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

"Insight into the worldwide epidemiology of inflammatory bowel disease is important for the identification of geographic patterns and time trends," said Gilaad G. Kaplan, MD, MPH, of the University of Calgary and lead author of this study. "Our findings will help researchers estimate the global public health burden of inflammatory bowel disease so that appropriate health-care resources are allocated, and targeted research is conducted in specific geographic regions," added Dr. Kaplan, an Alberta Innovates Health Solutions population health investigator. View a video in which he discusses the study's findings and implications, and a patient recalls his experiences with Crohn's disease, a major illness recognized most often as IBD.

Population-based epidemiologic data of IBD collected in a standardized fashion in developing nations are sparse. To properly interpret the incidence or prevalence data and evaluate trends, researchers conducted a systematic review of all population-based studies that describe the incidence and/or prevalence of IBD. They found that the incidence of IBD is increasing or stable in virtually every region of the world that has been studied.

Researchers found that the highest prevalence of IBD worldwide was reported in Canada and Europe, whereas Asia had a lower prevalence of IBD. In developing nations, IBD was a rare occurrence; however, as these nations have become more industrialized, the incidence of IBD has increased. Gender differences were inconsistent, suggesting that the disease occurred equally among females and males.

Universally, incidence rates for both Crohn's disease and ulcerative colitis were highest among individuals who were between 20 and 40 years old. Thus, IBD affects individuals in the most healthy and productive years of life, resulting in long-term cost to the patient, health-care system and society.

Despite more than 200 publications in the literature on IBD, this study highlights the need for incidence and prevalence data in many regions of the world, particularly from developing countries. Future studies in these regions are required to provide important insights into the etiology of IBD.

The two major illnesses that are recognized most often as inflammatory bowel disease are ulcerative colitis and Crohn's disease. The most common symptoms of ulcerative colitis, which occurs in the inner lining of the colon (large intestine) or rectum, are diarrhea, abdominal cramps and rectal bleeding. Patients suffering from Crohn's disease, an inflammation and ulceration process that occurs in the deep layers of the intestinal wall, experience pain in the abdomen often in the lower right side diarrhea, weight loss and occasionally bleeding.

Contact: Alissa J. Cruz
American Gastroenterological Association

Related medicine news :

1. Hepatitis B virus reemerges with long-term nucleoside analog treatment
2. Are Global Market Forces Linked to Obesity Epidemic?
3. Transending Borders Towards Global Health
4. Emory and US CDC partner to continue building global public health network with $6 million grant
5. Global conference on stem cell therapy to be held Jan. 25-27, 2012 in New York City
6. Global Carbon Project annual emissions summary
7. Mistaken identity: New report highlights the global impact of medical misdiagnosis
8. Good intentions may hamper progress in pursuit of global reproductive health and rights
9. Bigger birds in central California, courtesy of global climate change
10. Smart city, smart village proposals progress as Malaysias global advisory council meets
11. Close-up on endometriosis at 40th AAGL Global Congress
Post Your Comments:
(Date:11/24/2015)... ... , ... Aided by seed funding from the Ron Foley Foundation, researchers at ... into how to detect and treat pancreatic cancer (PC). , WCHN researchers will ... molecules (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... for its exceptional customer service: the TrustDale certification. The award recognizes good companies ... Baltimore stone honing , tile and grout, and hard surface restoration company earned ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... patented products, announces Innovative Blending, a household invention that revolutionizes the vending machine ... & Smoothie Bars market is worth $2 billion," says Scott Cooper, CEO and ...
(Date:11/24/2015)... ... November 24, 2015 , ... GBCHealth and Global Health ... bestowed annually to the world’s best corporate-supported global health programs. The awards ... Landscape Symposium held in Washington D.C and attended by over 150 representatives from ...
(Date:11/24/2015)... Miami, Fl (PRWEB) , ... November 24, 2015 , ... ... Farms. Adding houseplants is an easy and affordable way to bring long-lasting style and ... “green heroes” also provide oxygen, clean the air and keep on giving all year ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015 iRhythm Technologies, Inc. , a leading ... announced that it will participate in the 27th Annual Piper Jaffray ... New York, NY . Kevin King , Chief ... 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm is ...
(Date:11/24/2015)... Teledyne DALSA , a Teledyne Technologies company ... introduce its CMOS X-Ray detector for mammography at ... December 3, at McCormick Place in Chicago ... interventional imaging will be on display in the South Hall, ... CMOS X-Ray detectors is the industry benchmark for high speed ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology: